You are here

  • Home
  • Archive
  • Volume 23, Issue Suppl 1
  • DI-002 Effectiveness and safety of deferasirox in the treatment of transfusional iron overload in myelodysplastic syndrome in clinical practice

Article metrics

Article menu
Download PDFPDF
Drug information and pharmacotherapy
DI-002 Effectiveness and safety of deferasirox in the treatment of transfusional iron overload in myelodysplastic syndrome in clinical practice

 

Online download statistics by month:

Online download statistics by month: March 2016 to September 2024

AbstractFullPdf
Mar 20161100
Apr 2016301
Jun 2016500
Jul 2016501
Aug 2016100
Sep 2016300
Oct 2016200
Nov 2016300
Dec 2016100
Jan 2017300
Feb 2017902
Mar 2017100
Apr 2017500
May 2017600
Jun 2017800
Jul 2017300
Aug 20171200
Sep 2017400
Oct 2017600
Nov 2017400
Dec 20171600
Jan 2018800
Feb 2018400
Mar 20181800
Apr 2018600
May 20185601
Jun 20181000
Jul 20181201
Aug 20182200
Sep 2018400
Oct 2018400
Nov 20181600
Dec 20181000
Jan 20191000
Feb 20193000
Mar 2019400
Apr 2019601
May 2019200
Jun 2019300
Jul 2019200
Aug 2019800
Sep 2019400
Oct 20192000
Nov 2019800
Dec 20192200
Jan 20202400
Feb 20201400
Mar 20201800
Apr 2020100
May 20201300
Jun 20201800
Jul 2020400
Aug 2020400
Sep 20202000
Oct 20202600
Nov 20203900
Dec 20201000
Jan 2021400
Feb 2021002
Mar 2021200
Apr 2021400
Oct 2021200
Nov 20211200
Dec 2021600
Feb 2022600
Mar 2022800
Apr 2022200
May 20221200
Jun 2022200
Jul 20221000
Aug 20221001
Sep 2022400
Oct 2022600
Nov 20221000
Dec 20221100
Jan 2023400
Feb 2023600
Mar 20231701
Apr 2023700
May 20231200
Jun 2023400
Jul 2023400
Aug 2023600
Sep 2023800
Oct 2023200
Nov 2023400
Dec 20231000
Jan 2024800
Feb 20241000
Mar 20241200
Apr 2024800
May 20241200
Jun 20241800
Jul 2024600
Aug 20241000
Sep 20241100
Total881011